Analyst's projection sparked by the US drug group's plans to scale back discovery work on diabetes, as well as hepatitis C and neuroscience

Formula 1 chief gives evidence as he fights $140m legal claim and shows his instinct for power has not been dimmed by the years

Data reveal investment company has moved for $5bn in Ukrainian debt after a similar risk taken by Michael Hasenstab in Ireland paid off